Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Hydration for dry eye disease in adults with type 2 diabetes and diabetic neuropathy
ACTRN12620001346965Phase 4Not yet recruiting
- Sponsor
- University of New South Wales
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Systane HYDRATION and saline in dry eye syndrome (DED) (2 arms), sponsored by University of New South Wales. Primary endpoints: Ocular Surface Disease Index score, Corneal and conjunctival staining and 1 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
Systane HYDRATIONsaline
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ACTRN12620001346965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001346965.